- About Us
- Nano-Social Network
- Nano Consulting
- My Account
The Medical Devices Manufacturers Association (MDMA) joined over 200 other organizations to express concerns with The Patent Reform Act of 2007, S.1145 and H.R. 1908.
In a letter sent to key members of the House and Senate Judiciary Committees, a diverse set of stakeholders stated that the Patent Reform Act would "hinder innovation across the diverse sectors of the American economy we represent, including academia, agriculture, alternative energy, biotechnology, chemical, electronics, environmental technology, financial services, information technology, life sciences, nanotechnology, and telecommunications."
The letter highlights three shared areas of concern and recommends striking the Act's most controversial and inequitable proposals:
-- Language pertaining to the apportionment of damages;
-- The creation of an open-ended post-grant review process;
-- The granting of unprecedented rulemaking authority for the Patent and
In addition to MDMA, signatories of the letter include the Biotechnology Industry Organization Association, the Innovation Alliance, the NanoBusiness Alliance, CropLife America, the Association of University Technology Managers, the Institute of Electrical and Electronics Engineers, the Small Business Exporters Association of the United States, the Small Business Technology Council, and the Center for Small Business and the Environment. Many state organizations and individual companies ranging from small startups to the Fortune 500 were also represented as signatories.
MDMA's Executive Director, Mark Leahey, stated, "the current bill would severely undermine investment and innovation in every industry, including medical technology." Leahey continued, "the diverse nature of signatories demonstrates the far reaching implications this legislation will have on the patent system and we urge Congress to make the recommended changes to ensure America's innovation economy continues to flourish."
To read the letter, please visit the following link: http://www.medicaldevices.org/public/documents/PatentReformLetterFinal06.19.07_000.pdf
About Medical Devices Manufacturers Association (MDMA)
The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C. that represents independent manufacturers of medical devices, diagnostic products and healthcare information systems.
For more information, please click here
MARK B. LEAHEY, ESQ.
1350 I Street NW, Suite 540
Washington, DC 20005
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Electro-optical switch transmits data at record-low temperatures: Operating at temperatures near absolute zero, switch could enable significantly faster data processing with lower power consumption March 20th, 2017
AIM Photonics Welcomes Coventor as Newest Member: US-Backed Initiative Taps Process Modeling Specialist to Enable Manufacturing of High-Yield, High-Performance Integrated Photonic Designs March 16th, 2017
Researchers develop groundbreaking process for creating ultra-selective separation membranes: Discovery could greatly improve energy-efficiency of separation and purification processes in the chemical and petrochemical industries March 15th, 2017
Rare-earths become water-repellent only as they age March 22nd, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Intertronics introduce new nanoparticle deagglomeration technology March 15th, 2017
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016